Cambridge Investment Research Advisors’s ProShares S&P MidCap 400 Dividend Aristocrats ETF REGL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio REGL Stock Details REGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.37M	Buy	80,468 +2,787	+4%	+$249K	0.02%	823
2026 Q1	$6.71M	Sell	77,681 -387	-0.5%	-$34.4K	0.02%	805
2025 Q4	$6.58M	Sell	78,068 -462	-0.6%	-$38.8K	0.02%	777
2025 Q3	$6.7M	Sell	78,530 -14,937	-16%	-$1.26M	0.02%	753
2025 Q2	$7.62M	Buy	93,467 +7,120	+8%	+$568K	0.02%	655
2025 Q1	$6.96M	Sell	86,347 -7,579	-8%	-$617K	0.02%	645
2024 Q4	$7.58M	Buy	93,926 +188	+0.2%	+$15.7K	0.03%	602
2024 Q3	$7.67M	Buy	93,738 +159	+0.2%	+$12.5K	0.03%	604
2024 Q2	$6.89M	Sell	93,579 -10,556	-10%	-$798K	0.03%	608
2024 Q1	$8.18M	Sell	104,135 -13,786	-12%	-$1.02M	0.03%	529
2023 Q4	$8.68M	Sell	117,921 -13,629	-10%	-$933K	0.04%	462
2023 Q3	$8.78M	Buy	131,550 +7,753	+6%	+$543K	0.04%	422
2023 Q2	$8.7M	Buy	123,797 +10,942	+10%	+$760K	0.04%	428
2023 Q1	$7.98M	Buy	112,855 +14,335	+15%	+$1.04M	0.04%	439
2022 Q4	$7.05M	Buy	98,520 +24,883	+34%	+$1.76M	0.04%	469
2022 Q3	$4.74M	Sell	73,637 -47,410	-39%	-$3.33M	0.03%	592
2022 Q2	$8.17M	Buy	121,047 +60,287	+99%	+$4.23M	0.04%	394
2022 Q1	$4.39M	Buy	60,760 +1,348	+2%	+$96.3K	0.02%	692
2021 Q4	$4.38M	Buy	59,412 +1,021	+2%	+$73.2K	0.02%	701
2021 Q3	$3.96M	Buy	58,391 +3,032	+5%	+$215K	0.02%	716
2021 Q2	$3.95M	Sell	55,359 -14,637	-21%	-$1.06M	0.02%	734
2021 Q1	$4.88M	Buy	69,996 +857	+1%	+$57K	0.03%	575
2020 Q4	$4.35M	Sell	69,139 -257	-0.4%	-$15.2K	0.03%	581
2020 Q3	$3.68M	Buy	69,396 +2,220	+3%	+$121K	0.02%	565
2020 Q2	$3.54M	Buy	67,176 +14,028	+26%	+$701K	0.03%	546
2020 Q1	$2.39M	Sell	53,148 -3,149	-6%	-$174K	0.02%	599
2019 Q4	$3.39M	Sell	56,297 -5,247	-9%	-$309K	0.03%	598
2019 Q3	$3.58M	Buy	61,544 +2,493	+4%	+$144K	0.03%	539
2019 Q2	$3.45M	Buy	59,051 +7,251	+14%	+$418K	0.03%	528
2019 Q1	$2.92M	Buy	51,800 +20,525	+66%	+$1.14M	0.03%	571
2018 Q4	$1.62M	Buy	31,275 +2,540	+9%	+$139K	0.02%	712
2018 Q3	$1.64M	Buy	28,735 +4,332	+18%	+$245K	0.02%	766
2018 Q2	$1.33M	Buy	24,403 +588	+2%	+$31.7K	0.01%	827
2018 Q1	$1.26M	Buy	23,815 +4,947	+26%	+$265K	0.01%	819
2017 Q4	$1.03M	Buy	18,868 +4,338	+30%	+$233K	0.01%	893
2017 Q3	$760K	Sell	14,530 -466	-3%	-$24K	0.01%	982
2017 Q2	$772K	Buy	14,996 +3,299	+28%	+$170K	0.01%	938
2017 Q1	$605K	Buy	11,697 +3,331	+40%	+$171K	0.01%	975
2016 Q4	$421K	Buy	8,366 +3,708	+80%	+$177K	0.01%	1097
2016 Q3	$217K	Buy	+4,658	New	+$218K	﹤0.01%	1504

Other funds holding REGL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $7.99B AUM 24.2% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cambridge Investment Research Advisors's REGL Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) stake by 3.6% in Q2 2026, buying an estimated $249K and bringing the position to 80,468 shares worth $7.37M. The position accounts for 0.02% of the portfolio, ranked #823.

Cambridge Investment Research Advisors first reported a position in REGL in Q3 2016 and has held it in 40 quarters since. The position peaked at $8.78M in Q3 2023. 240 funds tracked by Wall St. Rank hold REGL as of Q2 2026.

Cambridge Investment Research Advisors held 80,468 shares of ProShares S&P MidCap 400 Dividend Aristocrats ETF worth $7.37M as of Q2 2026.
Cambridge Investment Research Advisors bought 2,787 ProShares S&P MidCap 400 Dividend Aristocrats ETF shares in Q2 2026, an estimated $249K.
ProShares S&P MidCap 400 Dividend Aristocrats ETF made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #823 holding.
Cambridge Investment Research Advisors first reported a position in ProShares S&P MidCap 400 Dividend Aristocrats ETF in Q3 2016 and has held it in 40 quarters since.
Cambridge Investment Research Advisors's ProShares S&P MidCap 400 Dividend Aristocrats ETF position peaked at $8.78M in Q3 2023.
240 funds tracked by Wall St. Rank held ProShares S&P MidCap 400 Dividend Aristocrats ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.